Thesis is a pioneering healthtech organization dedicated to addressing the critical challenges in modern healthcare. By developing an intelligent, AI-powered platform, the company enables care teams to work more efficiently, effectively increasing clinical capacity and allowing providers to focus on what matters most: patient care.
With $60 million in funding from prominent investors like Oak HC/FT and CRV, Thesis is positioned for significant impact. The company fosters a high-performance environment where technology meets clinical empathy, offering employees the opportunity to build products that tackle real-world health challenges at scale.